Prevalence of both diagnosed and
undiagnosed diabetes
Among the U.S. population overall, crude estimates for 2021
were:
38.4 million people of all ages—or 11.6% of the U.S.
population—had diabetes.
Diagnosed: 29.7 million people, including 29.4 million
adults
38.1 million adults aged 18 years or older—or 14.7% of
all U.S. adults—had diabetes.
8.7 million adults aged 18 years or older who met
laboratory criteria for diabetes were not aware of or
did not report having diabetes. This number represents 3.4% of all U.S.
adults and 22.8% of all U.S. adults with
diabetes.
The percentage of adults with diabetes increased with
age, reaching 29.2% among those aged 65 years or older.
Prevalence of prediabetes among adults
An estimated 97.6 million adults aged 18 years or older had
prediabetes in 2021.
65 years or older: 27.2 million people aged 65 years or
older (48.8%) have prediabetes
Among U.S. adults aged 18 years or older, crude estimates for
2017–2020 were:
38.0% of all U.S. adults had prediabetes, based on their fasting
glucose or A1C level).
19.0% of adults with prediabetes reported being told by a health
professional that they had this condition.
Among U.S. adults aged 18 years or older, age-adjusted data for
2017–2020 indicated:
10.8% of adults had prediabetes, based on both elevated
fasting plasma glucose and A1C levels.
A higher percentage of men (41.0%) than women (32.0%)
had prediabetes, based on their fasting glucose or A1C
level.
Prevalence of prediabetes (based on fasting glucose or
A1C level) was similar among all racial and ethnic
groups and education levels.
Prevalence of diagnosed diabetes
Among the U.S. population overall, crude estimates for 2021 were:
29.7 million people of all ages—or 8.9% of the U.S. population—had
diagnosed diabetes.
352,000 children and adolescents younger than age 20 years—or 35 per
10,000 U.S. youths—had diagnosed diabetes. This includes 304,000
with type 1 diabetes.
1.7 million adults aged 20 years or older—or 5.7% of all U.S. adults
with diagnosed diabetes—reported both having type 1 diabetes and
using insulin.
3.6 million adults aged 20 years or older—or 12.3% of all U.S.
adults with diagnosed diabetes—started using insulin within a year
of their diagnosis.
Among U.S. adults aged 18 years or older, age-adjusted data for
2019–2021 indicated the following:
For both men and women, prevalence of diagnosed diabetes
was highest among American Indian and Alaska Native
adults (13.6%), followed by non-Hispanic Black adults
(12.1%), adults of Hispanic origin (11.7%), non-Hispanic
Asian adults (9.1%) and non-Hispanic White adults
(6.9%).
Prevalence varied significantly by education level,
which is an indicator of socioeconomic status.
Specifically, 13.1% of adults with less than a high
school education had diagnosed diabetes versus 9.1% of
those with a high school education and 6.9% of those
with more than a high school education.
Adults with family income above 500% of the federal
poverty level had the lowest prevalence for both men
(6.3%) and women (3.9%).
For both men and women, prevalence was higher among adults living in
nonmetropolitan areas compared to those in metropolitan areas.
Costs
The total direct and indirect estimated costs* of
diagnosed diabetes in the United States in 2022 was $413
billion.
Total direct estimated costs of diagnosed diabetes
increased from $227 billion in 2012 to $307 billion in
2022 (2022 dollars). Total indirect costs increased from
$89 billion to $106 billion in the same period (2022
dollars).
From 2012 to 2022, excess medical costs per person
associated with diabetes increased from $10,179 to
$12,022 (2022 dollars).
* Direct costs = medical costs; indirect costs = lost
productivity from work-related absenteeism, reduced
productivity at work and at home, unemployment from chronic
disability, and premature mortality.
Deaths
In 2021, diabetes was the eighth leading cause of death
in the United States. This finding is based on 103,294
death certificates in which diabetes was listed as the
underlying cause of death (crude rate, 31.1 per 100,000
people).
In 2021, there were 399,401 death certificates with
diabetes listed as the underlying or contributing cause
of death (crude rate, 120.3 per 100,000 people).
Emergency Department Visits
In 2020, about 16.8 million emergency department visits were
reported with diabetes as any listed diagnosis among adults
aged 18 years or older, including:
267,000 for hyperglycemic crisis (11.4 per 1,000 adults
with diabetes).
202,000 for hypoglycemia (8.6 per 1,000 adults with
diabetes).
Hospitalizations
In 2020, a total of 7.86 million hospital discharges were
reported with diabetes as any listed diagnosis among U.S.
adults aged 18 years or older (335.4 per 1,000 adults with
diabetes).
These discharges included:
1.68 million for major cardiovascular diseases (71.6 per
1,000 adults with diabetes), including:
368,000 for ischemic heart disease (15.7 per 1,000
adults with diabetes).
321,000 for stroke (13.7 per 1,000 adults with
diabetes).
160,000 for a lower-extremity amputation (6.8 per 1,000
adults with diabetes).
232,000 for hyperglycemic crisis (9.9 per 1,000 adults
with diabetes).
51,000 for hypoglycemia (2.2 per 1,000 adults with
diabetes).
Overweight & Obesity
89.8% were overweight or had obesity, defined as a body
mass index (BMI) of 25 kg/m2 or
higher.
Specifically:
26.9% were overweight (BMI of 25.0 to 29.9 kg/m2).
47.1% had obesity (BMI of 30.0 to 39.9 kg/m2).
15.7% had extreme obesity (BMI of 40.0 kg/m2 or
higher).
High Blood Pressure
80.6% had a systolic blood pressure of 130 mmHg or
higher or diastolic blood pressure of 80 mmHg or higher
or were on prescription medication for their high blood
pressure.
70.8% had a systolic blood pressure of 140 mmHg or
higher or diastolic blood pressure of 90 mmHg or higher
or were on prescription medication for their high blood
pressure.
High Cholesterol
39.5% had a non-HDL level of 130 mg/dL or higher.
Specifically:
19.9% had a non-HDL level of 130 to 159 mg/dL.
11.5% had a non-HDL level of 160 to 189 mg/dL.
8.0% had a non-HDL level of 190 mg/dL or higher.
* Non-high-density lipoprotein cholesterol (non-HDL)
contains all the atherogenic lipoproteins, including
low-density lipoprotein cholesterol (LDL), very-low-density
lipoprotein, lipoprotein(a), and others. Growing evidence
supports non-HDL as a better predictor of cardiovascular
disease risk than LDL.